康惠制药：8月19日召开董事会会议

Group 1 - The company announced the convening of its 18th meeting of the 5th Board of Directors on August 19, 2025, to discuss the revision of certain governance systems [2] - For the year 2024, the company's revenue composition is as follows: pharmaceutical manufacturing accounts for 49.58%, pharmaceutical distribution accounts for 47.35%, and other businesses account for 3.07% [2]